Fuji Pharma Co., Ltd. (TYO:4554)

Revenue by Product

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012	Sep 30, 2011	Sep 30, 2010	Sep 30, 2009	Sep 30, 2008	Sep 30, 2007	Sep 30, 2006	Sep 30, 2005
Product - Hormones	18.02B
Product - Hormones Growth	12.29%
Product - Others	11.74B
Product - Others Growth	19.20%
Product - Diagnostic Drugs	8.06B
Product - Diagnostic Drugs Growth	5.06%
Product - Metabolic Drugs	2.08B
Product - Metabolic Drugs Growth	0.92%
Product - Tissue Cell Function Drug	1.28B
Product - Tissue Cell Function Drug Growth	26.73%
Merchandise - Hormones	1.21B
Merchandise - Hormones Growth	30.59%
Product - Nervous System and Sensory Organ Agents	716.00M
Product - Nervous System and Sensory Organ Agents Growth	-4.41%
Product - Antibiotics and Chemotherapeutic Agents	533.00M
Product - Antibiotics and Chemotherapeutic Agents Growth	-15.40%
Product - Cardiovascular Drugs	469.00M
Other	219.00M
Other Growth	-59.37%

Revenue by Geography

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012	Sep 30, 2011	Sep 30, 2010	Sep 30, 2009	Sep 30, 2008	Sep 30, 2007	Sep 30, 2006	Sep 30, 2005
Japan	46.14B
Japan Growth	12.84%